cure for foot and mouth?, page-2

  1. 345 Posts.
    Prr seem to have been developing nicely and although a biased opinion managemnet claims that the value of their intellectual property far exceeds the current share price.
    Their portfolio of research projects focus on the following areas:
    -technology that has the potential to both prevent and treat Malaria
    -development of tumour antigens to target cancer cells of the breast, lungs, colon, ovaries and prostate
    -development of new drugs for rheumatoid athritis
    -producing an immune response in large animals leading to a vaccination against foot and mouth disease.
    Several licences and royalties in the pipeline with significant announcements due in July. Worth a punt at current levels, who knows how this one may run if any one of their technologies is a hit.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
27.0¢
Change
0.010(3.85%)
Mkt cap ! $396.3M
Open High Low Value Volume
27.5¢ 27.5¢ 26.5¢ $161.1K 593.0K

Buyers (Bids)

No. Vol. Price($)
26 319448 26.5¢
 

Sellers (Offers)

Price($) Vol. No.
27.0¢ 85773 25
View Market Depth
Last trade - 14.58pm 29/07/2025 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.